SPERSALLERG

This brand name is authorized in Poland, Romania, South Africa.

Active ingredients

The drug SPERSALLERG contains a combination of these active pharmaceutical ingredients (APIs):

1	Antazoline UNII FP8Q8F72JH - ANTAZOLINE HYDROCHLORIDE
	Antazoline is an antagonist of histamine H1 receptors. It selectively bind to but does not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.
	Read more about Antazoline
2	Tetryzoline UNII 0YZT43HS7D - TETRAHYDROZOLINE HYDROCHLORIDE
	Tetryzoline is an alpha adrenergic receptor agonist, which is used in form of nasal solution or spray for decongestion of nasal and nasopharyngeal mucosa.
	Read more about Tetryzoline

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R01AC04	Antazoline	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AC Antiallergic agents, excl. corticosteroids
Discover more medicines within R01AC04
S01GA52	Tetryzoline, combinations	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GA Sympathomimetics used as decongestants
Discover more medicines within S01GA52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
PL	Rejestru Produktów Leczniczych	100062593
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W58787001
ZA	Health Products Regulatory Authority	36/26/0357